Ignite Creation Date:
2024-05-06 @ 7:37 PM
Last Modification Date:
2024-10-26 @ 3:10 PM
Study NCT ID:
NCT06078384
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-11
First Post:
2023-10-05
Brief Title:
Pembrolizumab and Chemotherapy Treatment or no Treatment Guided by the Level of TILs in Resected Early-stage TNBC
Sponsor:
Organization:
UNICANCER